Angiotensin II for Vasodilatory Shock?

June 19, 2017 • 00:17:50
Angiotensin II for Vasodilatory Shock?
Critical Care Perspectives in Emergency Medicine
Angiotensin II for Vasodilatory Shock?

Jun 19 2017 | 00:17:50

/

Show Notes

This month Mike McCurdy rejoins the podcast to discuss the ATHOS-3 trial.  Mike was one of the co-authors on this impressive publication and gives us insight into the study and its results.  Very thought provoking!

You can get CME credit for this episode here! Click here for CME Account Creation Instructions

Other Episodes

Episode 0

June 24, 2019 • 00:26:09
Episode Cover

Anticoagulation Reversal for ICH

ICH accounts for approximately 15 percent of all strokes.  Despite improvements in neurocritical care, the mortality for patients with ICH can still reach 50...

Listen

Episode 0

July 21, 2019 • 00:19:47
Episode Cover

Critically Ill Patients with Vibrio Infection

With increasing water temperatures, there is a rise in the incidence of V.vulnificus infections in non-endemic regions.  Patients with V.vulnificus infection are often critically...

Listen

Episode 0

October 04, 2022 • 00:25:21
Episode Cover

Does a Restrictive Oxygenation Target Make a Difference in the Post-Arrest Patient?

The care of patients with return of spontaneous circulation following cardiac arrest centers on optimizing oxygenation and ventilation, optimizing hemodynamics, identifying patients that require...

Listen